- Home
- GOVX vs TIRX Comparison
GOVX vs TIRX Comparison
Compare GOVX & TIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- TIRX
- Stock Information
- Founded
- GOVX 2001
- TIRX 2010
- Country
- GOVX United States
- TIRX China
- Employees
- GOVX N/A
- TIRX N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- TIRX Specialty Insurers
- Sector
- GOVX Health Care
- TIRX Finance
- Exchange
- GOVX Nasdaq
- TIRX Nasdaq
- Market Cap
- GOVX 16.8M
- TIRX 18.6M
- IPO Year
- GOVX N/A
- TIRX 2021
- Fundamental
- Price
- GOVX $0.41
- TIRX $0.82
- Analyst Decision
- GOVX Strong Buy
- TIRX
- Analyst Count
- GOVX 2
- TIRX 0
- Target Price
- GOVX $7.00
- TIRX N/A
- AVG Volume (30 Days)
- GOVX 524.6K
- TIRX 58.7K
- Earning Date
- GOVX 11-13-2025
- TIRX 08-22-2025
- Dividend Yield
- GOVX N/A
- TIRX N/A
- EPS Growth
- GOVX N/A
- TIRX N/A
- EPS
- GOVX N/A
- TIRX N/A
- Revenue
- GOVX $3,353,560.00
- TIRX N/A
- Revenue This Year
- GOVX N/A
- TIRX N/A
- Revenue Next Year
- GOVX N/A
- TIRX N/A
- P/E Ratio
- GOVX N/A
- TIRX N/A
- Revenue Growth
- GOVX 8.52
- TIRX 158.74
- 52 Week Low
- GOVX $0.37
- TIRX $0.60
- 52 Week High
- GOVX $3.01
- TIRX $6.45
- Technical
- Relative Strength Index (RSI)
- GOVX 35.66
- TIRX 40.94
- Support Level
- GOVX $0.37
- TIRX $0.65
- Resistance Level
- GOVX $0.44
- TIRX $0.94
- Average True Range (ATR)
- GOVX 0.03
- TIRX 0.09
- MACD
- GOVX -0.00
- TIRX 0.03
- Stochastic Oscillator
- GOVX 26.59
- TIRX 43.70
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About TIRX TIAN RUIXIANG Holdings Ltd
Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.